TEL AVIV, Israel, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Enlight Renewable Energy (TASE & NASDAQ: ENLT), a leading global renewable energy developer and an independent power producer, will release its financial results for the fourth quarter and full year ended December 31, 2025, before market open on Tuesday, February 17, 2026. The earnings release with the financial results as well as additional investor materials will be accessible on the Company’s website at https://enlightenergy.co.il/data/financial-reports ...

The transactions represent an issuance of up to 2.25 million shares of SATA in the aggregateDALLAS, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Strive, Inc. (Nasdaq: SATA) (“Strive” or the “Company”) today announced the pricing of its follow-on offering (the “offering”) on January 22, 2026 of 1,320,000 shares of Strive’s Variable Rate Series A Perpetual Preferred Stock (the “SATA Stock”), an upsize over the $150 million transaction size previously announced when taken together with the anticipated privately negotiate ...

Core Insights - American Rare Earths, through its subsidiary Wyoming Rare, has been awarded a STAR Project grant in partnership with the University of Wyoming to assess potential byproducts from rare earth elements at the Halleck Creek Project [2][9] - The STAR Project is part of the NSF-funded ART initiative aimed at promoting applied research with high commercialization potential [3][7] Company Overview - American Rare Earths is a critical minerals company focused on reshaping the U.S. rare earths industry, particularly through the Halleck Creek Project, which is positioned to enhance U.S. critical mineral independence [10][11] - The Halleck Creek Project is located on Wyoming State land and utilizes cost-efficient open-pit mining methods, benefiting from streamlined permitting processes [10][11] Project Details - The STAR Project will involve examining tailings and byproducts from rare earth extraction, exploring their potential applications, and assessing their technical viability and economic implications [4][5] - Deliverables include a comprehensive database of material properties, evaluations of potential uses through computational modeling, and small-scale laboratory experiments [5] Research and Development - The project aims to create marketable innovations and solve real-world problems through applied, industry-sponsored research [6] - The collaboration with the University of Wyoming's School of Energy Resources emphasizes the importance of interdisciplinary research and outreach to support Wyoming's energy sector [8]

Core Viewpoint - Reliance Global Group, Inc. is changing its ticker symbol from "RELI" to "EZRA" on January 26, 2026, to better reflect its strategic evolution and focus on technology acquisitions [1][2]. Group 1: Ticker Symbol Change - The ticker symbol change aims to align with the formation of EZRA International Group, which will focus on acquiring controlling stakes in technology companies, particularly in sectors like cybersecurity, AI, FinTech, InsurTech, MedTech, and digital health [2]. - The transition to the new ticker symbol will not require any action from shareholders, and existing share certificates will remain valid [4]. Group 2: Acquisition Strategy - The company has announced plans to acquire a majority stake in Scentech, an AI diagnostics firm specializing in non-invasive disease detection technologies, marking the first acquisition under EZRA International Group [3]. - This acquisition strategy is designed to identify and scale breakthrough technologies that can create long-term value, complementing the stable cash flow from the company's insurance holdings [4]. Group 3: Company Overview - Reliance Global Group, Inc. is an InsurTech pioneer utilizing AI and cloud technologies to enhance efficiencies in the insurance industry [5]. - The company's platforms, including RELI Exchange and 5minuteinsure.com, provide tools for independent insurance agencies and competitive online insurance quotes for consumers [5].

Core Viewpoint - Premium Income Corporation has successfully completed an overnight treasury offering of 2,633,000 Preferred Shares, generating gross proceeds of approximately $42.65 million [1][2]. Group 1: Offering Details - The offering is expected to close around January 29, 2026, pending approval from the Toronto Stock Exchange [2]. - Preferred Shares are priced at $16.20 each, while the last trading price was $16.46 as of January 21, 2026 [2]. - Since inception, the total dividends declared on the Preferred Shares amount to $25.96 per share [2]. Group 2: Investment Strategy - The Fund primarily invests in common shares of major Canadian banks, including Bank of Montreal, The Bank of Nova Scotia, and others [3]. - To enhance returns beyond dividend income, the Fund will selectively write covered call and put options on some or all common shares in its portfolio [3]. Group 3: Financial Information - Preferred Shares provide fixed cumulative preferential monthly cash distributions of $0.10625, equating to an annual yield of 8.50% based on the original issue price of $15.00 [4]. - The offering is led by National Bank Financial Inc. as the syndicate of agents [4].

Core Viewpoint - The Total Return Securities Fund has successfully completed its tender offer, purchasing 4 million shares at a price of $6.81 per share [1]. Group 1 - The tender offer by Total Return Securities Fund, previously known as The Swiss Helvetia Fund, expired on January 20, 2026, at 5:00 p.m. New York City time [1]. - The Fund accepted all 4 million shares offered for payment [1].

Core Viewpoint - The launch of the 21shares Dogecoin ETF (TDOG) provides U.S. investors with regulated and transparent exposure to Dogecoin through a physically backed exchange-traded fund structure, beginning trading on NASDAQ on January 22, 2026 [1][4]. Company Overview - 21shares is a leading issuer of cryptocurrency exchange-traded funds (ETFs) and has a track record of creating innovative investment solutions in the crypto space, including the world's first physically-backed crypto ETP in 2018 [8][9]. - The company has partnered with the House of Doge to enhance the accessibility and utility of Dogecoin, aiming to support its mainstream adoption [11][6]. Product Details - TDOG offers a 1:1 backing of Dogecoin in institutional-grade custody, allowing investors to gain exposure without the complexities of digital wallets or crypto exchanges [2]. - The ETF has a management fee of 0.50% and is not registered under the Investment Company Act of 1940, meaning it is not subject to the same regulations as traditional ETFs [4][3]. Market Context - The Dogecoin ecosystem is maturing, with increasing merchant adoption and a strong community, which supports its growth potential [5]. - The launch of TDOG follows the introduction of the 21shares Solana ETF (TSOL) and the 21shares 2x Long Dogecoin ETF (TXXD), indicating a strategic expansion in the crypto ETF market [4][7]. Strategic Partnerships - 21shares has formed a partnership with FalconX to create a full-service digital assets provider, enhancing its market access and growth potential across North America, Latin America, and Europe [7].

GETTYSBURG, Pa., Jan. 22, 2026 (GLOBE NEWSWIRE) -- ACNB Corporation (NASDAQ: ACNB) (“ACNB” or the “Corporation”), financial holding company for ACNB Bank and ACNB Insurance Services, Inc., announced net income of $10.8 million, or $1.04 diluted earnings per share, for the three months ended December 31, 2025 compared to net income of $6.6 million, or $0.77 diluted earnings per share, for the three months ended December 31, 2024 and compared to net income of $14.9 million, or $1.42 diluted earnings per share ...

Core Insights - Polyrizon Ltd. has initiated a key usability study for its lead product candidate, NASARIX™, aimed at confirming alignment with FDA requirements and supporting clinical development [1][2] Group 1: Product Development - NASARIX™ is an innovative intranasal allergy blocker designed for broad consumer use, representing a significant advancement in Polyrizon's development roadmap [1][2] - The usability study is intended to de-risk downstream regulatory review and facilitate a streamlined path toward clinical trials [2][3] Group 2: Regulatory Milestones - Successful completion of the usability program will provide essential regulatory evidence for NASARIX™'s readiness for clinical evaluation, with trials expected to commence in Q3 2026 [3][4] - The study underscores the company's commitment to FDA-aligned development, patient safety, and user-centered solutions [4] Group 3: Company Overview - Polyrizon specializes in developing innovative medical device hydrogels delivered as nasal sprays, which create a barrier against viruses and allergens [4] - The proprietary Capture and Contain™ hydrogel technology aims to function as a "biological mask" in the nasal cavity, with ongoing development focused on enhancing bioadhesion and retention [4]

Core Insights - Edible Garden AG Incorporated has expanded its product availability by launching its Pickle Party and Pulp lines in Safeway stores, enhancing consumer access to functional and flavorful food options [1][2][5] Company Overview - Edible Garden is a leader in controlled environment agriculture (CEA), focusing on sustainable, locally grown organic produce and innovative farming solutions [6] - The company operates over 5,000 retail locations across the U.S., Caribbean, and South America, utilizing advanced farming technologies and sustainable practices [6][8] Product Launch - The Pickle Party line is positioned as the world's first functional pickle line, featuring raw, refrigerated, fermented, Kosher, and Non-GMO products made through traditional fermentation methods [3] - Pulp complements the Pickle Party line by offering fermented gourmet and chili-based sauces, appealing to consumers seeking bold flavors [4] Retail Partnership - Safeway, a major U.S. supermarket chain with over 900 stores, is known for its commitment to quality and fresh offerings, making it an ideal partner for Edible Garden's product expansion [2][5] - The partnership reflects Safeway's strategy to enhance its assortment of better-for-you products that align with consumer demand for clean ingredients and functional benefits [2][5]